AGGRENOX Side Effects

7014331-2 | Chills, Eye Irritation, Headache
on Sep 15, 2010 Male patient from , 87 years of age, was diagnosed with transient ischaemic attack and was treated with Aggrenox (View Usage). Patient experienced the following unwanted or unexpected effects: chills, eye irritation, headache (What is headache?). Aggrenox dosage: .

7014327-0 | Blood Pressure Increased, Headache, Nausea
Patient was taking Aggrenox (View Usage). Patient had the following side effects: blood pressure increased, headache (What is headache?), nausea (What is nausea?) on Sep 13, 2010 from Additional patient health information: Female patient , 76 years of age, was diagnosed with transient ischaemic attack, blood cholesterol increased, cardiac disorder and. Aggrenox dosage: . During the same period patient was treated with SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), ASPIRIN (View Aspirin Review and Aspirin Label ).

7011005-9 | Headache, Hyperhidrosis, Nausea
Adverse event was reported on Sep 22, 2010 by a Female patient taking Aggrenox (View Usage) (Dosage: 1 2 Po) was diagnosed with cerebrovascular accident and. Location: UNITED STATES , 63 years of age, weighting 133.0 lb, After Aggrenox was administered, patient had the following side effects: headache (What is headache?), hyperhidrosis, nausea (What is nausea?).

7010809-6 | Headache
on Sep 23, 2010 Female patient from UNITED STATES , 80 years of age, weighting 142.0 lb, was diagnosed with transient ischaemic attack and was treated with Aggrenox (View Usage). Patient experienced the following unwanted or unexpected effects: headache (What is headache?). Aggrenox dosage: . During the same period patient was treated with LIPITOR (View Lipitor Review and Lipitor Label ), ALPHAGAN (View Alphagan Review and Alphagan Label ), COLACE (View Colace Review and Colace Label ), VICODIN (View Vicodin Review and Vicodin Label ), XALATAN (View Xalatan Review and Xalatan Label ), SYNTHROID (View Synthroid Review and Synthroid Label ), PRINIVIL (View Prinivil Review and Prinivil Label ), PRILOSEC (View Prilosec Review and Prilosec Label ). Patient was hospitalized.


7007871-3 | Muscle Spasms, Pain In Extremity
on Sep 07, 2010 Female patient from , 78 years of age, was diagnosed with transient ischaemic attack, irritable bowel syndrome (What is irritable bowel syndrome?), blood cholesterol increased, prophylaxis, sjogren's syndrome (What is sjogren's syndrome?), hypertension, musculoskeletal discomfort, fibromyalgia and was treated with Aggrenox (View Usage). Patient had the following side effects: muscle spasms, pain in extremity. Aggrenox dosage: . During the same period patient was treated with BELLADINNA (View Belladinna Review and Belladinna Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), PROMETRIUM (View Prometrium Review and Prometrium Label ), ESTRODIOL (View Estrodiol Review and Estrodiol Label ), LABETALOL HCL (View Labetalol Hcl Review and Labetalol Hcl Label ), SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ), DIAZEPAM (View Diazepam Review and Diazepam Label ), SERTRALINE HYDROCHLORIDE (View Sertraline Hydrochloride Review and Sertraline Hydrochloride Label ).

6979631-0 | Cholecystitis, Duodenal Ulcer, Gallbladder Enlargement, Haemoglobin Decreased, Haemorrhage
Patient was taking Aggrenox (View Usage). After Aggrenox was administered, patient had the following side effects: cholecystitis, duodenal ulcer, gallbladder enlargement, haemoglobin decreased, haemorrhage on Sep 10, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 134.0 lb, was diagnosed with transient ischaemic attack and. Aggrenox dosage: 1 2x/day Po. Patient was hospitalized.

6976246-5 | Anaemia, Device Occlusion, Gastrointestinal Haemorrhage, Haemorrhoids, Hypovolaemia, Post Procedural Haematuria, Rectal Haemorrhage, Renal Failure Acute, Urinary Retention
Adverse event was reported on Sep 02, 2010 by a Male patient taking Aggrenox (View Usage) (Dosage: ) was diagnosed with bladder cancer (What is bladder cancer?) and. Location: , weighting 194.4 lb, Patient experienced the following unwanted or unexpected effects: anaemia, device occlusion, gastrointestinal haemorrhage, haemorrhoids, hypovolaemia, post procedural haematuria, rectal haemorrhage, renal failure acute, urinary retention. During the same period patient was treated with SUTENT (37.5 Mg) (View Sutent Review and Sutent Label ), LOPERAMIDE (LOPERAMIDE) (View Loperamide (loperamide) Review and Loperamide (loperamide) Label ), HYDRALAZINE HCL (View Hydralazine Hcl Review and Hydralazine Hcl Label ), LISINOPRIL HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE) (LISINOPRIL) (View Lisinopril Hydrochlorothiazide (hydrochlorothiazide) (lisinopril) Review and Lisinopril Hydrochlorothiazide (hydrochlorothiazide) (lisinopril) Label ), DOCUSATE SOCIUM (COLACE) (View Docusate Socium (colace) Review and Docusate Socium (colace) Label ), FERROUS SULFATE TAB (View Ferrous Sulfate Tab Review and Ferrous Sulfate Tab Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), ACTOS (View Actos Review and Actos Label ). Patient was hospitalized.

6972339-7 | Feeling Cold, Haematemesis, Nausea
on Aug 27, 2010 Female patient from , 68 years of age, was diagnosed with transient ischaemic attack, hypertension, type 2 diabetes mellitus and was treated with Aggrenox (View Usage). Patient had the following side effects: feeling cold, haematemesis, nausea (What is nausea?). Aggrenox dosage: 25mg/200mg, 1 Cap Bid. During the same period patient was treated with DILTIAZEM (View Diltiazem Review and Diltiazem Label ), ACARBOSE (View Acarbose Review and Acarbose Label ), GLIPIZIDE (View Glipizide Review and Glipizide Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), METFORMIN (View Metformin Review and Metformin Label ), HYDRALAZINE (View Hydralazine Review and Hydralazine Label ), METOPROLOL TARTRATE (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ).

6971385-7 | Thrombosis
on Sep 03, 2010 Male patient from , weighting 143.3 lb, was diagnosed with cerebrovascular disorder and was treated with Aggrenox (View Usage). After Aggrenox was administered, patient had the following side effects: thrombosis. Aggrenox dosage: .

6970136-X | Decreased Appetite
Patient was taking Aggrenox (View Usage). Patient experienced the following unwanted or unexpected effects: decreased appetite on Aug 26, 2010 from Additional patient health information: Male patient , 81 years of age, was diagnosed with cerebrovascular accident and. Aggrenox dosage: .

6969052-9 | Cerebrovascular Accident, Depression, Fatigue
Adverse event was reported on Sep 03, 2010 by a Male patient taking Aggrenox (View Usage) (Dosage: One Capsule Bid Po) was diagnosed with cerebrovascular accident and. Location: UNITED STATES , 82 years of age, weighting 165.0 lb, Patient had the following side effects: cerebrovascular accident, depression (What is depression?), fatigue.

6967219-7 | Loss Of Consciousness, Pruritus
on Aug 30, 2010 Female patient from , 83 years of age, was diagnosed with cerebrovascular accident, diabetes mellitus, cerebrovascular accident prophylaxis, hypertension and was treated with Aggrenox (View Usage). After Aggrenox was administered, patient had the following side effects: loss of consciousness, pruritus. Aggrenox dosage: . During the same period patient was treated with INSULIN (View Insulin Review and Insulin Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), ANTI HYPERTENSIVE (View Anti-hypertensive Review and Anti-hypertensive Label ). Patient was hospitalized.

6962540-0 | Choking, Obstructive Airways Disorder, Product Quality Issue, Throat Irritation, Vomiting
on Aug 27, 2010 Male patient from , 72 years of age, was diagnosed with cerebrovascular accident, migraine (What is migraine?), blood cholesterol increased, vitamin supplementation and was treated with Aggrenox (View Usage). Patient experienced the following unwanted or unexpected effects: choking (What is choking?), obstructive airways disorder, product quality issue, throat irritation, vomiting. Aggrenox dosage: 2 Anz. During the same period patient was treated with KEPPRA (View Keppra Review and Keppra Label ), LIPITOR (View Lipitor Review and Lipitor Label ), MULTI VITAMINS (View Multi-vitamins Review and Multi-vitamins Label ).

6960505-6 | Abdominal Pain Upper, Decreased Appetite, Diarrhoea, Dysuria, Weight Decreased
Patient was taking Aggrenox (View Usage). Patient had the following side effects: abdominal pain upper, decreased appetite, diarrhoea, dysuria, weight decreased on Aug 20, 2010 from Additional patient health information: Male patient , 77 years of age, was diagnosed with ruptured cerebral aneurysm, hiatus hernia, hypertension and. Aggrenox dosage: . During the same period patient was treated with PANTOPRAZOLE (View Pantoprazole Review and Pantoprazole Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), METOPROLOL TARTRATE (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), POTASSIUM (View Potassium Review and Potassium Label ).

6958694-2 | Gastrointestinal Haemorrhage, Haematemesis, Haematochezia
Adverse event was reported on Aug 27, 2010 by a Male patient taking Aggrenox (View Usage) (Dosage: ) was diagnosed with transient ischaemic attack and. Location: , 53 years of age, weighting 195.1 lb, After Aggrenox was administered, patient had the following side effects: gastrointestinal haemorrhage, haematemesis, haematochezia. During the same period patient was treated with NSAID (View Nsaid Review and Nsaid Label ). Patient was hospitalized.

6955961-3 | Ear Disorder, Headache, Hearing Impaired, Nausea
on Aug 17, 2010 Female patient from , 91 years of age, was diagnosed with cardiovascular disorder, diabetes mellitus and was treated with Aggrenox (View Usage). Patient experienced the following unwanted or unexpected effects: ear disorder, headache (What is headache?), hearing impaired, nausea (What is nausea?). Aggrenox dosage: . During the same period patient was treated with INSULIN (View Insulin Review and Insulin Label ).

6955249-0 | Choking Sensation, Tongue Disorder
on Aug 16, 2010 Male patient from , 79 years of age, was diagnosed with cerebrovascular accident prophylaxis and was treated with Aggrenox (View Usage). Patient had the following side effects: choking sensation, tongue disorder. Aggrenox dosage: . During the same period patient was treated with FLOMAX (0.4 Mg) (View Flomax Review and Flomax Label ).

6937129-X | Cerebrovascular Accident
Patient was taking Aggrenox (View Usage). After Aggrenox was administered, patient had the following side effects: cerebrovascular accident on Aug 17, 2010 from Additional patient health information: Female patient , 82 years of age, . Aggrenox dosage: .

6936869-6 | Loss Of Consciousness, Syncope
Adverse event was reported on Aug 16, 2010 by a Female patient taking Aggrenox (View Usage) (Dosage: 50/400) was diagnosed with cerebrovascular accident prophylaxis, blood cholesterol increased and. Location: , 72 years of age, Patient experienced the following unwanted or unexpected effects: loss of consciousness, syncope. During the same period patient was treated with SYNTHROID (View Synthroid Review and Synthroid Label ), ZOCOR (View Zocor Review and Zocor Label ), CALCIUM (View Calcium Review and Calcium Label ), VITAMIN D (View Vitamin D Review and Vitamin D Label ).

6934129-0 | Anaemia, Gastrointestinal Haemorrhage, Hypovolaemia, Post Procedural Haematuria, Rectal Haemorrhage, Renal Failure Acute, Urinary Retention
on Aug 13, 2010 Male patient from , 71 years of age, weighting 194.4 lb, was diagnosed with bladder cancer (What is bladder cancer?) and was treated with Aggrenox (View Usage). Patient had the following side effects: anaemia, gastrointestinal haemorrhage, hypovolaemia, post procedural haematuria, rectal haemorrhage, renal failure acute, urinary retention. Aggrenox dosage: . During the same period patient was treated with SUTENT (37.5 Mg) (View Sutent Review and Sutent Label ), LOPERAMIDE (LOPERAMIDE) (View Loperamide (loperamide) Review and Loperamide (loperamide) Label ), HYDRALAZINE HCL (View Hydralazine Hcl Review and Hydralazine Hcl Label ), LISINOPRIL HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE) (LISINOPRIL) (View Lisinopril Hydrochlorothiazide (hydrochlorothiazide) (lisinopril) Review and Lisinopril Hydrochlorothiazide (hydrochlorothiazide) (lisinopril) Label ), DOCUSATE SOCIUM (COLACE) (View Docusate Socium (colace) Review and Docusate Socium (colace) Label ), FERROUS SULFATE TAB (View Ferrous Sulfate Tab Review and Ferrous Sulfate Tab Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), ACTOS (View Actos Review and Actos Label ). Patient was hospitalized.

6931617-8 | Femoral Neck Fracture
on Aug 07, 2010 Male patient from , 99 years of age, was treated with Aggrenox (View Usage). After Aggrenox was administered, patient had the following side effects: femoral neck fracture. Aggrenox dosage: .

6922489-6 | Tonsillar Hypertrophy
Patient was taking Aggrenox (View Usage). Patient experienced the following unwanted or unexpected effects: tonsillar hypertrophy on Aug 02, 2010 from Additional patient health information: Female patient , 54 years of age, was diagnosed with cerebrovascular accident prophylaxis and. Aggrenox dosage: 25mg/200mg.

6913689-X | Alopecia
Adverse event was reported on Aug 06, 2010 by a Female patient taking Aggrenox (View Usage) (Dosage: ) . Location: UNITED STATES , 65 years of age, Patient had the following side effects: alopecia.

6913452-X | Ageusia
on Aug 04, 2010 Female patient from UNITED STATES , weighting 112.0 lb, was treated with Aggrenox (View Usage). After Aggrenox was administered, patient had the following side effects: ageusia. Aggrenox dosage: .

6888164-1 | Cox-maze Procedure, Mitral Valve Repair, Transient Ischaemic Attack
on Jul 27, 2010 Male patient from , weighting 164.2 lb, was diagnosed with heart rate abnormal and was treated with Aggrenox (View Usage). Patient experienced the following unwanted or unexpected effects: cox-maze procedure, mitral valve repair, transient ischaemic attack. Aggrenox dosage: . During the same period patient was treated with COUMADIN (4 Mg) (View Coumadin Review and Coumadin Label ), MULTAQ (800 Mg) (View Multaq Review and Multaq Label ), DIGOXIN (0.25 Mg) (View Digoxin Review and Digoxin Label ).

6887217-1 | Tongue Disorder
Patient was taking Aggrenox (View Usage). Patient had the following side effects: tongue disorder on Jul 16, 2010 from Additional patient health information: Male patient , 79 years of age, was diagnosed with cerebrovascular accident prophylaxis and. Aggrenox dosage: . During the same period patient was treated with FLOMAX (0.4 Mg) (View Flomax Review and Flomax Label ).

6884103-8 | Lethargy
Adverse event was reported on Jul 15, 2010 by a Female patient taking Aggrenox (View Usage) (Dosage: ) was diagnosed with cerebrovascular accident, depression (What is depression?), asthma (What is asthma?) and. Location: , 76 years of age, After Aggrenox was administered, patient had the following side effects: lethargy. During the same period patient was treated with LITHIUM (View Lithium Review and Lithium Label ), ZYPREXA (View Zyprexa Review and Zyprexa Label ), EFFEXOR (View Effexor Review and Effexor Label ), ADVAIR DISKUS 100/50 (View Advair Diskus 100/50 Review and Advair Diskus 100/50 Label ).

6884098-7 | Cough, Foreign Body
on Jul 14, 2010 Male patient from , 60 years of age, was diagnosed with cerebrovascular accident and was treated with Aggrenox (View Usage). Patient experienced the following unwanted or unexpected effects: cough, foreign body. Aggrenox dosage: .

6883516-8 | Cerebrovascular Accident
on Jul 23, 2010 Male patient from , 52 years of age, was treated with Aggrenox (View Usage). Patient had the following side effects: cerebrovascular accident. Aggrenox dosage: . Patient was hospitalized.

6881983-7 | Abdominal Distension, Arthralgia, Constipation, Disturbance In Attention, Fatigue, Headache, Nausea
Patient was taking Aggrenox (View Usage). After Aggrenox was administered, patient had the following side effects: abdominal distension, arthralgia, constipation (What is constipation?), disturbance in attention, fatigue, headache (What is headache?), nausea (What is nausea?) on Jul 07, 2010 from Additional patient health information: Female patient , 63 years of age, was diagnosed with cerebrovascular accident, coeliac disease, asthma (What is asthma?), blood cholesterol increased and. Aggrenox dosage: . During the same period patient was treated with MIRALAX (View Miralax Review and Miralax Label ), TVAR INHALER (View Tvar Inhaler Review and Tvar Inhaler Label ), CHLORTRIMATON (View Chlortrimaton Review and Chlortrimaton Label ), DIOVAN (View Diovan Review and Diovan Label ), LOVASTATIN (View Lovastatin Review and Lovastatin Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), NIACIN (View Niacin Review and Niacin Label ), ASPIRIN (View Aspirin Review and Aspirin Label ).

6881978-3 | Intervertebral Disc Disorder, Plasmacytosis
Adverse event was reported on Jul 20, 2010 by a Female patient taking Aggrenox (View Usage) (Dosage: ) was diagnosed with cerebrovascular accident prophylaxis, hypertension, blood cholesterol increased and. Location: , 67 years of age, Patient experienced the following unwanted or unexpected effects: intervertebral disc disorder, plasmacytosis. During the same period patient was treated with METOPROLOL TARTRATE (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ), CRESTOR (View Crestor Review and Crestor Label ).

6879870-3 | Anaemia, Gastrointestinal Haemorrhage, Hypovolaemia, Post Procedural Haematuria, Rectal Haemorrhage, Renal Failure Acute, Urinary Retention
on Jul 20, 2010 Male patient from , 71 years of age, weighting 194.4 lb, was diagnosed with bladder cancer (What is bladder cancer?) and was treated with Aggrenox (View Usage). Patient had the following side effects: anaemia, gastrointestinal haemorrhage, hypovolaemia, post procedural haematuria, rectal haemorrhage, renal failure acute, urinary retention. Aggrenox dosage: . During the same period patient was treated with SUTENT (37.5 Mg) (View Sutent Review and Sutent Label ), LOPERAMIDE (LOPERAMIDE) (View Loperamide (loperamide) Review and Loperamide (loperamide) Label ), HYDRALAZINE HCL (View Hydralazine Hcl Review and Hydralazine Hcl Label ), LISINOPRIL HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE) (LISINOPRIL) (View Lisinopril Hydrochlorothiazide (hydrochlorothiazide) (lisinopril) Review and Lisinopril Hydrochlorothiazide (hydrochlorothiazide) (lisinopril) Label ), DOCUSATE SOCIUM (COLACE) (View Docusate Socium (colace) Review and Docusate Socium (colace) Label ), FERROUS SULFATE TAB (View Ferrous Sulfate Tab Review and Ferrous Sulfate Tab Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), ACTOS (View Actos Review and Actos Label ). Patient was hospitalized.

6878734-9 | Faeces Discoloured, Haematochezia
on Jul 22, 2010 Female patient from , 74 years of age, was treated with Aggrenox (View Usage). After Aggrenox was administered, patient had the following side effects: faeces discoloured, haematochezia. Aggrenox dosage: Every 1 Day(s). During the same period patient was treated with APO FAMOTIDINE (View Apo-famotidine Review and Apo-famotidine Label ), CRESTOR (View Crestor Review and Crestor Label ), ELTROXIN (View Eltroxin Review and Eltroxin Label ), ENTROPHEN (View Entrophen Review and Entrophen Label ), EZETROL (View Ezetrol Review and Ezetrol Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ), PMS CITALOPRAM (View Pms-citalopram Review and Pms-citalopram Label ), SANDOZ DILTIAZEM T (View Sandoz Diltiazem T Review and Sandoz Diltiazem T Label ).

6867195-1 | Bone Disorder, Central Nervous System Lesion, Spinal Disorder
Patient was taking Aggrenox (View Usage). Patient experienced the following unwanted or unexpected effects: bone disorder, central nervous system lesion, spinal disorder on Jul 22, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 143.0 lb, was diagnosed with cerebrovascular accident prophylaxis and. Aggrenox dosage: 1 Capsule 2 X Day.

6860985-0 | Blood Glucose Increased, Cerebrovascular Accident, Chromaturia, Dizziness, Hemiparesis
Adverse event was reported on Jul 12, 2010 by a Female patient taking Aggrenox (View Usage) (Dosage: ) was diagnosed with cerebrovascular accident prophylaxis and. Location: , 62 years of age, Patient had the following side effects: blood glucose increased, cerebrovascular accident, chromaturia, dizziness (What is dizziness?), hemiparesis. Patient was hospitalized and became disabled.

6844499-X | Menopause, Skin Ulcer, Transient Ischaemic Attack
on Jul 08, 2010 Female patient from , 40 years of age, was diagnosed with cerebrovascular accident and was treated with Aggrenox (View Usage). After Aggrenox was administered, patient had the following side effects: menopause (What is menopause?), skin ulcer, transient ischaemic attack. Aggrenox dosage: 50mg/400mg. During the same period patient was treated with ATENOLOL (View Atenolol Review and Atenolol Label ), SERTRALINE HCL (View Sertraline Hcl Review and Sertraline Hcl Label ).

6844428-9 | Choking, Obstructive Airways Disorder, Throat Irritation, Vomiting
on Jul 08, 2010 Male patient from , 72 years of age, was diagnosed with cerebrovascular accident, migraine (What is migraine?), blood cholesterol increased, vitamin supplementation and was treated with Aggrenox (View Usage). Patient experienced the following unwanted or unexpected effects: choking (What is choking?), obstructive airways disorder, throat irritation, vomiting. Aggrenox dosage: 2 Anz. During the same period patient was treated with KEPRA (View Kepra Review and Kepra Label ), LIPITOR (View Lipitor Review and Lipitor Label ), MULTI VITAMINS (View Multi-vitamins Review and Multi-vitamins Label ).

6843897-8 | Cerebrovascular Accident, Hypoaesthesia Facial, Transient Ischaemic Attack
Patient was taking Aggrenox (View Usage). Patient had the following side effects: cerebrovascular accident, hypoaesthesia facial, transient ischaemic attack on Jul 12, 2010 from Additional patient health information: Female patient , weighting 150.0 lb, was diagnosed with cerebrovascular accident prophylaxis and. Aggrenox dosage: . During the same period patient was treated with HYDROCHLOROTHIAZIDE (12.5 Mg) (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), METOPROLOL (50 Mg) (View Metoprolol Review and Metoprolol Label ), ARICEPT (100 Mg) (View Aricept Review and Aricept Label ), LISINOPRIL (40 Mg) (View Lisinopril Review and Lisinopril Label ), NORVASC (10 Mg) (View Norvasc Review and Norvasc Label ), LIPITOR (40 Mg) (View Lipitor Review and Lipitor Label ), LANTUS (80 U) (View Lantus Review and Lantus Label ). Patient was hospitalized.

6835437-4 | Tongue Disorder
Adverse event was reported on Jun 28, 2010 by a Male patient taking Aggrenox (View Usage) (Dosage: ) was diagnosed with cerebrovascular accident prophylaxis and. Location: , 79 years of age, After Aggrenox was administered, patient had the following side effects: tongue disorder. During the same period patient was treated with FLOMAX (0.4 Mg) (View Flomax Review and Flomax Label ).

6811937-8 | Intervertebral Disc Disorder, Plasmacytosis
on Jun 28, 2010 Female patient from , 67 years of age, was diagnosed with cerebrovascular accident, hypertension, blood cholesterol increased and was treated with Aggrenox (View Usage). Patient experienced the following unwanted or unexpected effects: intervertebral disc disorder, plasmacytosis. Aggrenox dosage: . During the same period patient was treated with METOPROLOL TARTRATE (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ), CRESTOR (View Crestor Review and Crestor Label ).

6801249-0 | Blood Pressure Diastolic Increased, Headache, Malaise
on Jun 16, 2010 Female patient from , 71 years of age, was diagnosed with transient ischaemic attack, hypertension, blood cholesterol increased and was treated with Aggrenox (View Usage). Patient had the following side effects: blood pressure diastolic increased, headache (What is headache?), malaise. Aggrenox dosage: 25/200; 50mg/400mg. During the same period patient was treated with ATENOLOL (View Atenolol Review and Atenolol Label ), LIPITOR (View Lipitor Review and Lipitor Label ).

6794692-X | Dizziness, Somnolence
Patient was taking Aggrenox (View Usage). After Aggrenox was administered, patient had the following side effects: dizziness (What is dizziness?), somnolence on Jun 11, 2010 from Additional patient health information: Female patient , 63 years of age, was diagnosed with transient ischaemic attack, depression (What is depression?) and. Aggrenox dosage: . During the same period patient was treated with SERTRALINE HCL (View Sertraline Hcl Review and Sertraline Hcl Label ).

6781560-2 | Subdural Haematoma
Adverse event was reported on Jun 17, 2010 by a Female patient taking Aggrenox (View Usage) (Dosage: ) was diagnosed with carotid artery occlusion, multiple sclerosis (What is multiple sclerosis?) and. Location: , weighting 141.1 lb, Patient experienced the following unwanted or unexpected effects: subdural haematoma. During the same period patient was treated with REBIF (View Rebif Review and Rebif Label ), PLAVIX (View Plavix Review and Plavix Label ), ASPIRIN (325 Mg) (View Aspirin Review and Aspirin Label ). Patient was hospitalized.

6775677-6 | Aortic Arteriosclerosis, Dehydration, Gastritis Erosive, Groin Pain, Headache, Hypokalaemia, Hyponatraemia, Liver Injury, Nausea
on Jun 17, 2010 Female patient from , 84 years of age, weighting 154.3 lb, was diagnosed with thrombosis prophylaxis, hypertension, osteoarthritis (What is osteoarthritis?), hypothyroidism, nausea (What is nausea?) and was treated with Aggrenox (View Usage). Patient had the following side effects: aortic arteriosclerosis, dehydration, gastritis erosive, groin pain, headache (What is headache?), hypokalaemia, hyponatraemia, liver injury, nausea (What is nausea?). Aggrenox dosage: 2 Anz. During the same period patient was treated with ENABETA COMP (1 Anz) (View Enabeta Comp Review and Enabeta Comp Label ), IBUPROFEN (1200 Mg) (View Ibuprofen Review and Ibuprofen Label ), INDOMETHACIN SODIUM (100 Mg) (View Indomethacin Sodium Review and Indomethacin Sodium Label ), FELOCOR (5 Mg) (View Felocor Review and Felocor Label ), LEVOTHYROXINE SODIUM (50 Mcg) (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), METOCLOPRAMIDE (36 Mg) (View Metoclopramide Review and Metoclopramide Label ). Patient was hospitalized.

6774559-3 | Headache, Retching, Vomiting
on Jun 04, 2010 Female patient from , 87 years of age, was diagnosed with transient ischaemic attack and was treated with Aggrenox (View Usage). After Aggrenox was administered, patient had the following side effects: headache (What is headache?), retching, vomiting. Aggrenox dosage: .

6769659-8 | Aortic Arteriosclerosis, Dehydration, Gastritis Erosive, Groin Pain, Headache, Hypokalaemia, Hyponatraemia, Liver Injury, Nausea
Patient was taking Aggrenox (View Usage). Patient experienced the following unwanted or unexpected effects: aortic arteriosclerosis, dehydration, gastritis erosive, groin pain, headache (What is headache?), hypokalaemia, hyponatraemia, liver injury, nausea (What is nausea?) on Jun 08, 2010 from Additional patient health information: Female patient , 84 years of age, weighting 154.3 lb, was diagnosed with thrombosis prophylaxis, hypertension, osteoarthritis (What is osteoarthritis?), hypothyroidism, nausea (What is nausea?) and. Aggrenox dosage: 2 Anz. During the same period patient was treated with ENABETA COMP (1 Anz) (View Enabeta Comp Review and Enabeta Comp Label ), IBUPROFEN (1200 Mg) (View Ibuprofen Review and Ibuprofen Label ), INDOMETHACIN SODIUM (100 Mg) (View Indomethacin Sodium Review and Indomethacin Sodium Label ), FELOCOR (5 Mg) (View Felocor Review and Felocor Label ), LEVOTHYROXINE SODIUM (50 Mcg) (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), METOCLOPRAMIDE (36 Mg) (View Metoclopramide Review and Metoclopramide Label ). Patient was hospitalized.

6769416-2 | Chest Pain, Dyspnoea, Headache, Hyperhidrosis, Palpitations
Adverse event was reported on Jun 10, 2010 by a Male patient taking Aggrenox (View Usage) (Dosage: ) was diagnosed with cerebrovascular accident prophylaxis, type 2 diabetes mellitus, blood cholesterol increased, hypertension, depression (What is depression?) and. Location: , 56 years of age, Patient had the following side effects: chest pain (What is chest pain?), dyspnoea, headache (What is headache?), hyperhidrosis, palpitations. During the same period patient was treated with ACTOS (View Actos Review and Actos Label ), PRAVASTATIN (View Pravastatin Review and Pravastatin Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), TRILIPIX (View Trilipix Review and Trilipix Label ), COREG (View Coreg Review and Coreg Label ), HCTZ (View Hctz Review and Hctz Label ), CELEXA (View Celexa Review and Celexa Label ), DIOVAN (View Diovan Review and Diovan Label ).

6769413-7 | Transient Ischaemic Attack
on Jun 10, 2010 Male patient from , 57 years of age, was diagnosed with cerebrovascular accident and was treated with Aggrenox (View Usage). After Aggrenox was administered, patient had the following side effects: transient ischaemic attack. Aggrenox dosage: . During the same period patient was treated with SIMVASTATIN (40 Mg) (View Simvastatin Review and Simvastatin Label ), VITAMIN B COMPLEX CAP (View Vitamin B Complex Cap Review and Vitamin B Complex Cap Label ), CEREFOLIN NAC (View Cerefolin Nac Review and Cerefolin Nac Label ), LISINOPRIL (10 Mg) (View Lisinopril Review and Lisinopril Label ), OMEPRAZOLE (20 Mg) (View Omeprazole Review and Omeprazole Label ).

6759925-4 | Atrial Fibrillation, Blood Cholesterol Increased
on May 24, 2010 Female patient from , 78 years of age, was diagnosed with cerebrovascular accident prophylaxis, depression (What is depression?), hypothyroidism and was treated with Aggrenox (View Usage). Patient experienced the following unwanted or unexpected effects: atrial fibrillation (What is atrial fibrillation?), blood cholesterol increased. Aggrenox dosage: . During the same period patient was treated with LEXAPRO (View Lexapro Review and Lexapro Label ), EVISTA (View Evista Review and Evista Label ), M.V.I. (View M.v.i. Review and M.v.i. Label ), VITAMIN D (View Vitamin D Review and Vitamin D Label ).

6752688-8 | Abasia, Bladder Disorder, Dysstasia, Extradural Haematoma, Gait Disturbance, Hypoaesthesia, Intestinal Functional Disorder, Muscle Contracture, Nervous System Disorder
Patient was taking Aggrenox (View Usage). Patient had the following side effects: abasia, bladder disorder, dysstasia, extradural haematoma, gait disturbance, hypoaesthesia, intestinal functional disorder, muscle contracture, nervous system disorder on Jun 01, 2010 from UNITED STATES Additional patient health information: Female patient , 57 years of age, weighting 180.0 lb, was diagnosed with cerebrovascular accident prophylaxis and. Aggrenox dosage: One Capsule 2 X Day Po. During the same period patient was treated with LISINOPRIL (View Lisinopril Review and Lisinopril Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ). Patient was hospitalized.